Veru Inc VERU 深 沪
已收盘 10-02 16:00:00 美东时间
2.51
-0.030
-1.18%
华盛通- 最 高2.56
- 今 开2.56
- 成交量 10.50万股
- 最 低 2.50
- 昨 收 2.54
- 总市值 4.28万
- 52周最高 7.33
- 市盈率 静 --
- 换手率 0.62%
- 52周最低 2.05
- 委 比 79.26%
- 总股本 1.71万
- 历史最高 245.70
- 量 比 1.04
- 振 幅 2.36%
- 历史最低 2.05
- 每 手 1
- 风险率 0.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Veru refocuses sabizabulin on post-daraxonrasib oncology
The latest announcement is out from Veru ( ($VERU) ). On September 8, 2026, Ver...
09-08 20:47
Veru shares are trading higher after the company reported better-than-expected Q3 EPS results.
Veru shares are trading higher after the company reported better-than-expected Q3 EPS results.
08-10 23:06
Veru Non-GAAP EPS of -$0.30 beats by $0.02
Veru press release (VERU): Q3 Non-GAAP EPS of -$0.30 beats by $0.02. Cash, cash equivalents and restricted cash were $23.9 million as of June 30, 2026 versus $15.8 million as of September 30, 202...
08-10 18:52
Veru Q3 EPS $(0.30) Beats $(0.32) Estimate
Veru (NASDAQ:VERU) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.32) by 6.25 percent. This is a 40 percent increase over losses of $(0.50) per share from the same period last year.
08-10 18:35
Veru Completes Patient Enrollment In Phase 2b PLATEAU Clinical Trial To Evaluate Effect Of Oral Enobosarm 3 Mg Versus To Treat Obesity
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the completion of enrollment in the Phase 2b PLATEAU clinical study to evaluate the effect of oral enob...
07-27 20:14
美股夜盘 | 柏雅国际涨41.30%，Advanced Biomed涨31.21%
Digital Brands Group, Inc.涨-20.24%；Ryde Group涨-12.83%；Psyence Biomedical Ltd.涨-9.12%
07-20 08:05
Veru Announces $21.8M Sales ATM Program With Oppenheimer, Canaccord
Veru Announces $21.8M Sales ATM Program With Oppenheimer, Canaccord
07-03 04:13
Veru因与诺和诺德的供应协议股价飙升160%，市场现需证据支撑
维鲁（Veru）股价上涨160%，因诺和诺德（Novo Nordisk）将为其2b期PLATEAU试验免费提供司美格鲁肽（Wegovy），降低试验阻碍，市场押注...
06-15 15:27
Veru股价暴涨132%：与诺和诺德合作引发生物科技热潮
维鲁公司（VERU）股价盘中飙升132.0%，至5.22美元，交易价接近52周高点7.40美元，换手率301.19%。成交量激增至近5000万股，远高于日均5...
06-15 15:15
